What is the Share Price of Sandu Pharmaceuticals Ltd?

Sandu Pharmaceuticals Ltd share price is ₹50.00 As on 25 March, 2025|22:08

Home
>
Stocks
>
Sandu Pharmaceuticals Ltd

Sandu Pharmaceuticals Ltd Share Price

Q: What is the Market Cap of Sandu Pharmaceuticals Ltd?

The Market Cap of Sandu Pharmaceuticals Ltd is ₹50 As on 25 March, 2025|22:08

Q: What is PE Ratio of Sandu Pharmaceuticals Ltd?

The P/E ratio of Sandu Pharmaceuticals Ltd is 27.5 As on 25 March, 2025|22:08

Q: What is PB Ratio of Sandu Pharmaceuticals Ltd?

The PB ratio of Sandu Pharmaceuticals Ltd is 1.18 As on 25 March, 2025|22:08

₹ 0.00 0 (0%)
Updated on 01-01-1970 5:30 AM

Stock Rating

BSE

Pros 1

Cons 6

Sandu Pharmaceuticals Ltd Price Performance

Day's Low
₹0

Day's High
₹0

₹ 0

52-w low
₹0

52-w high
₹0

Day's open
₹0
Previous close
₹0
VWAP
₹0
Lower price band
₹0
Upper price band
₹0

Today's Market Action

Its last traded stock price on BSE was 50.00 down by -3.47%. The total volume of shares on NSE and BSE combined was 4,776 shares. Its total combined turnover was Rs 0.02 crores.

Sandu Pharmaceuticals Ltd Medium and Long Term Market Action

The stock price of Sandu Pharmaceuticals Ltd is down by -100% over the last one month. Don't forget to check the full stock price history in the table below.

Sandu Pharmaceuticals Ltd Fundamentals

Market Cap (Cr): 50
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Sandu Pharmaceuticals Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Sandu Pharmaceuticals Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Sandu Pharmaceuticals Ltd

Data not available.

Sandu Pharmaceuticals Ltd FAQ's

What is Share Price of Sandu Pharmaceuticals Ltd?

What is the Market Cap of Sandu Pharmaceuticals Ltd?

What is PE Ratio of Sandu Pharmaceuticals Ltd?

What is PB Ratio of Sandu Pharmaceuticals Ltd?

What is the CAGR of Sandu Pharmaceuticals Ltd?

How to Buy Sandu Pharmaceuticals Ltd Share?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Zero Debt
The company has almost nil to negligible debt to equity ratio of 0.00. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Poor Cash Flow Conversion
The business has very poor cash conversion ratio of only 27.94% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Low Pricing Power & High Competition
The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
Poor Corporate Governance
The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(25/03/2025)

100

Margin of Safety Index: High

100.00%

100.00% People are bullish about Sandu Pharmaceuticals Ltd

0.00%

0.00 % People are bearish about Sandu Pharmaceuticals Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %